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Analysis of carcinogen-DNA adducts has been regarded as a useful means of assessing human exposure to chemical carcinogens. We have estab-
lished a method for quantitation of 4-aminobiphenyl (4-ABP)-DNA adducts by alkaline hydrolysis and gas chromatography with negative ion chemical
ionization mass spectrometry (GC-NICI-MS). Aliquots of DNA (typically 100 pg/ml) were spiked with an internal standard,d,-4-ABP, and were
hydrolyzed in 0.05 N NaOH at 130°C overnight. The liberated 4-ABP was extracted with hexane and derivatized using pentafluoropropionic anhy-
dride in trimethylamine for 30 min at room temperature prior to GC-NICI-MS. With in vitro [3HIN-hydroxy-4-ABP modified DNA standards, we
observed 59 ± 7% (n = 9) recovery of the 4-ABP and a linear correlation between hydrolyzed 4-ABP and the adduct levels ranging from about 1 in
108to 1 in 104 nucleotides (r = 0.999, n = 9). The method was further validated bycomparison of the results with that obtained by the 3 P-postlabeling
method. There was excellent agreement (r = 0.994, p<0.001) between the two methods for quantitation of the adduct in eight samples of
Salmonella typhimurium DNA treated with 4-ABP and rat liver S9, although the 32P-postlabeling method gave slightly higher values. The DNA
adducts in 11 human lung and 8 urinary bladder mucosa specimens were then determined by our GC-NICI-MS method. The adduct levels were
found to be <0.32 to 49.5 adducts per 108 nucleotides in the lungs and <0.32 to 3.94 adducts per 108 nucleotides in the bladder samples. Our
results indicate that the alkaline hydrolysis/GC-NICI-MS method is sensitive, structure-selective, and accurate, and will be useful for molecular
dosimetry of human exposure to this carcinogen. - Environ Health Perspect 102(Suppl 6):11-16 (1994)
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Introduction
The covalent modification of DNA by
chemical carcinogens appears to be a critical
event in chemical carcinogenesis. As a
result, the analysis of carcinogen-DNA
adducts has been considered to be a useful
means of assessing human exposure to
chemical carcinogens. 4-Aminobiphenyl
(4-ABP) is a potent human urinary bladder
carcinogen and is present in significant
quantities in tobacco smoke (1). This aro-
matic amine is metabolically activated to
several electrophilic intermediates, which
then covalently bind to cell macromole-
cules. The reaction ofactivated 4-ABP with
DNA in vitro and in vivo in laboratory ani-
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mals is known to result in formation of
three to four nucleoside adducts. The pre-
dominant adduct is N-(deoxyguano-
sin-8-yl)-ABP (dG-C8-ABP), which
accounts for about 70% of the bound
radioactivity (2,3). Evidence for human
exposure to 4-ABP and its metabolic acti-
vation was initially obtained from the
detection of4-ABP-hemoglobin adducts in
humans, with higher levels being observed
in cigarette smokers versus nonsmokers
(4-6) and in patients with a history ofuri-
nary bladder cancer versus controls (7).
With recent advances in analytical
methodology, 4-ABP-DNA adducts have
been detected either by immunochemical
or 32P-postlabeling-HPLC techniques in
human lung or urinary bladder at levels
ranging from one adduct per 106 to one
adduct per I09 nucleotides (8,9). More
recendy, 4-ABP-DNA adducts were found
as smoking related adducts in human urinary
bladder biopsies using 32P-postlabeling
methods (10). These findings suggested
that 4-ABP is likely to be an important fac-
tor in the etiology oftobacco-related human
cancers. However, since these methods may
not always provide sufficient specificity and
precision, a sensitive, structure-specific, and
relatively simple method was warranted for
molecular dosimetry ofhuman exposure to
this carcinogen. Furthermore, a specific
methodology for confirmation of sample
analyses was also highly desirable.
Previous studies have shown that
C8-deoxyguanosine adducts of arylamines
2-amino-6-methyldipyrido[1,2-a:3',2'-d]-
imidazole (Glu-P-1) (11) and 2-aminofluo-
rene (12), are susceptible to hydrolysis in
sodium hydroxide or hydrazine to release
parent arylamines, respectively. These studies
encouraged us to investigate 4-ABP-adducted
DNA. In this article, we report the devel-
opment of a method for quantitation of
4-ABP-DNA adducts by alkaline hydrolysis
and gas chromatography with negative ion
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chemical ionization mass spectrometry
(GC-NICI-MS) analysis.
Materials and Methods
Chemicals
[2,2'-3H]N-Hydroxy-4-ABP (91.2 mCi/
mmoles) and unlabeled 4-ABP were
acquired from Chemsyn Science Labora-
tories (Lenexa, KS) and Aldrich Chemical
Co. (Milwaukee, WI), respectively. All
aqueous solutions for GC-MS analysis
were prepared with water distilled from a
dilute solution of KMnO4. Hexane
(Resi-analyzed grade) was obtained from
J.T. Baker Chemical Co. (Phillipsburg, NJ).
Trimethylamine in hexane was prepared by
adding 1 g reagent-grade trimethylamine
hydrochloride from Aldrich Chemical
Company, Inc. (Milwaukee, WI) to 2 ml
water, neutralizing with NaOH and
extracting into 5 ml hexane. Pentafluoro-
propionic anhydride (PFPA), purchased
from Pierce (Rockford, IL), was stored in
air-tight vials and replaced periodically.
The internal standard, d9-4-ABP, was a gift
of SR Tannenbaum (MIT Cambridge,
MA). A stock solution of d9-4-ABP in
methanol (20 jig/ml) was prepared and
stored at -20°C. Various dilutions were
made on each day of use. All the enzymes
for 32P-postlabeling assay were obtained
from Sigma Chemical Co. (St. Louis,
MO), except T4 polynucleotide kinase,
which was from U.S. Biochemical Corp.
(Cleveland, OH). [,y-32P]ATP (7000
Ci/mmole) was obtained from ICN
Radiochemicals (Irvine, CA). PEI-cellulose
thin-layer plates, manufactured by
Macherey-Nagel (no. 801053), were pur-
chased from Alltech Associates, Inc.
(Deerfield, IL). X-ray film was from
Eastman-Kodak (Dallas, TX). All other
chemicals were ofthehighestgrade available.
Preparation ofDNASamples
[3H]N-Hydroxy-4-ABP modified DNA
standard was prepared by the reaction of
radiolabeled N-hydroxy-4-ABP with calf
thymus DNA in 100 mM potassium citrate/
0.1 mM EDTA, pH 5, as described previ-
ously (2,3). The adduct levels were deter-
mined by enzymatic hydrolysis, HPLC,
and scintillation counting. The Salmonella
typhimurium TAI538 and TA98 DNA was
isolated from the bacteria treated with vari-
ous concentrations of4-ABP ranging from
5 to 24 pg/ml in the presence ofAroclor-
treated rat liver S9 under the conditions
described (13). The bacteria were digested
for 10 min with 0.1% SDS, 50 mM
Tris-HCl buffer (pH 7.9), 10 mM EDTA,
and 0.28 mg/ml proteinase K; DNA was
purified from the lysates as described (14).
Human lung and urinary bladder tissues
obtained by surgery or autopsy were from
the John A. McClellan Memorial Veterans
Hospital in Little Rock, AR. The DNA
was isolated by homogenization of the tis-
sue, lysis of the cells with SDS, digestion
with protease, and extraction with phenol
and chloroform/isoamyl alcohol; traces of
RNA were removed by digestion with
RNase and DNA was precipitated with
ethanol (15). The smoking histories ofthe
lung donors are shown in Table 1; however,
the smoking histories ofthe urinary bladder
donors were not available.
AlkalineHydrlysisof4-ABPfromDNA
Aliquots of DNA solution (typically 100
pg DNA/ml) in screw-capped tubes (13
x100 mm) were brought to 0.05 N with
respect to NaOH and extracted three times
with 2 ml of hexane before spiking with
internal standard, d9-4-ABP, (2 to 200 pg
in 10 pl methanol, for GC-NICI-MS
analysis) or 4-ABP (as UV marker for
HPLC analysis). The solution was then
heated at 130°C overnight (18 hr) in a
Temp-Blok module heater (Lab-Line
Instruments Inc., Melrose, IL) that had
been filled with sea sand. The samples were
then cooled to room temperature and the
released 4-ABP was extracted into hexane
(2 ml, twice). For HPLC analysis,
[3H]N-hydroxy-ABP-modified DNA was
hydrolyzed. After extraction, hexane was
removed and the residue redissolved in
methanol. The 4-ABP was separated by
HPLC on a Waters pBondapakC,8 column
(3.9 x 300 mm). Elution was carried out
with a linear gradient starting from 20%
methanol in water to 100% methanol over
25 min at a flow rate of 2 ml/min. Under
these conditions, the retention time of
4-ABP was 15.3 min. The eluate was col-
lected at 1-min intervals and mixed with
scintillation fluid for counting radioactivity
in a Tracor Model 688 Analytic Marker III
scintillation counter (Elk Grove, IL). For
GC-NICI-MS analysis, the extracted 4-
ABP and the internal standard were deriva-
tized as described below.
Derivatization of4-ABP
4-ABP was derivatized on the basis of the
procedure described previously (4). Briefly,
10 pl of trimethylamine in hexane was
added to the combined hexane extracts
obtained as described above in a test tube,
followed by 10 p1 of PFPA. After reaction
for 30 min at room temperature, the solvent
and excess reagents were removedbyvacuum
Table 1. 4-ABP-DNA adducts in human lung tissues.
Donor no. Smoking history 4-ABPadductsa
1 1.5 packs/day for5 year 3.68
2 1.5-2 packs/day 7.52
3 2 packs/day 1.54
4 Notavailable 4.26
5 Ex-smoker(0.5 pack/day) 17.60
6 Nonsmoker 1.41
7 1-2 packs/dayfor2 year 7.55
8 1 pack/dayfor66 yr 49.50
9 1-1.5 packs/day for 55 year NDb
10 Not available 4.26
11 Notavailable 637
aValues represent the number of dG-C8-ABP adducts
per 108 nucleotides. bNot detected. The adduct level
<0.32 adduct per 10 nucleotides.
centrifugation. The PFPA derivative of
4-ABP was redissolved in an appropriate
amount of hexane before injection to
GC-NICI-MS.
Gas Chromaphy-Mss
Spectometmy
GC-NICI-MS analyses were carried out
on a Varian 3400 gas chromatograph with
a SPI injector interfaced (225°C) to a
Finnigan 4000 mass spectrometer system
(Finnigan MAT, San Jose, CA).
Chromatographic separation was achieved
using a DB5 fused silica capillary column
(32 m x 0.25 mm id). Helium was used as
carrier gas at a head pressure of20 psi. The
column oven was heated from 60 to 180°C
at 20°C/min and then at 10°C/min to
250°C. Under these conditions, the reten-
tion times of the PFPA derivatives of
4-ABP and d9-4-ABP were about 7 min.
The mass spectrometer was operated in the
negative ion chemical ionization (NICI)
mode with an electron energy of 100 eV.
Methane gas was admitted to an indicated
ion source pressure ofabout 0.25 torr and
the source temperature was maintained at
220°C. Quantification was accomplished
using selected ion monitoring (SIM) ofthe
(M-HF) ions of the PFPA derivatives of
4-ABP (m/z 295) and d9-4-ABP (m/z 304).
Data were processed by an INCOS data
system using IDOS 2 software.
Calculions
The integrated peak area of the 295 ion
was divided by the peak area ofthe 304 ion
and then multiplied by the ratio of the
molecularweights oftherespective compounds
(169/178) and by the amount of internal
standard added to determine the amount
(in picograms) of 4-ABP in the sample.
This value was corrected by the recovery,
divided by the amount in micrograms of
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7.3 7.7
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Figure 1. SIM chromatograms forthe analysis of 4-ABP (m/z295) andd9-4-ABP (m/z 304). The tra
from samples: (A) [3HIN-hydroxy-ABP-modified DNA containing 8.4 adducts/105 nucleotides; (B
no. 7; and (C) human urinary bladder DNA no. 2.
DNA in the sample and by the molecular
weight of 4-ABP to calculate the binding
level, expressed as pmole 4-ABP per mg
DNA or as adducts/1 6nudeotides.
32P-Postdabeling Detennination of
dG-C8-ABP
32P-Postlabeling assays were carried out
essentially based on the method described
by Gupta et al. (16). Briefly, the DNA
samples and [3H]N-hydroxy-4-ABP-modi-
fied DNA standards (each 5 pg DNA) were
hydrolyzed to 3'-nucleotides with 0.2 unit
ofmicrococcal endonuclease and 2.5 pg of
spleen phosphodiesterase by incubation at
370C for 3 hr. Adducted nucleotides were
enriched by n-butanol extraction (17).
Samples were then [5'-32P]phosphorylated
at 37°C for 40 min using 3 units of
polynucleotide kinase and 200 pCi of
[y-32P]ATP. Eight microliters ofthe labeled
mixture (2 pig DNA) was spotted in dupli-
cate on PEI-cellulose sheets and developed
in four directions (16,17) with buffers as
follows: Dl and D2 buffers consisted of
1.7 M sodium phosphate, pH 6.0; D3 and
D4 buffers contained 3.6 M lithium for-
mate/8.5 M urea (pH 3.5) and 1.2 M
lithium chloride/0.5 M Tris-HCl/8.0 M
urea (pH 8.0), respectively. The adducts
were located by autoradiography and the
corresponding area of the dG-C8-ABP on
the sheets was excised and the 32P radioac-
tivity determined by Cerenkov counting.
The adduct levels were quantitated by
comparing the radioactivity in the spot to
the corresponding spot fro
analysis of [3H]N-hydroxy-4-
DNA standards. Using the
fromabout I in 108to I in (
the standard curve was linea
lation coefficient of0.999.
Results
Hydrolysis Conditions
Preliminary experiments wer
determine the yield of 4-Al
from dG-C8-ABP and 4-4
DNA and to optimize the I
ditions. [IH]N-Hydroxy-4
DNA (100 pg/mi) and [3-
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or NaOH from 0.01 to 1 I
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respectively (data not shom
the NaOH concentration t'
increase theyield further. The
product, 4-ABP, subjected
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(n=3). These hydrolysis c(
then employed in the furth
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(C) Validation oftheMethod
Alkaline hydrolysis of 4-ABP from the
4-ABP-adducted DNA and subsequent
GC-NIC-MS analysis was validated using
in vitro [3H]N-hydroxy-ABP-modified calf
thymus DNA in which the adduct levels
were known by measuring the radioactivity
of the bound [3H]4-ABP residues,2and by
comparison ofthis method to the P-post-
labeling method for quantitation of
dG-C8-ABP adducts in the DNA isolated
from S. typhimurium strains TA1538 and
TA98, which were treated with various
concentrations of 4-ABP under the condi-
| tions used for mutagenicity assays as
77 described in Materials and Methods.
[3H]4-ABP-adducted DNA with levels
from one adduct per 108 to one adduct per
c r0c nucleotides was analyzed by the
icehuman lung DNA method. A representative chromatogram of
one ofthese samples is shown in Figure 1A.
The yield of 4-ABP from the 4-ABP-
adducted DNA was found to be 59 ± 7%
m the parallel (n=9) and this result was consistent with
-ABP-modified that obtained by HPLC analysis. An excel-
adduct levels lent correlation (r = 0.999, n = 9) was
05nucleotides, observed between hydrolyzed 4-ABP
r with a corre- amounts and the adduct levels in the DNA
(Figure 2). The detection limit is 10 fmoles
4-ABP per mg DNA (0.32 adduct per 108
nucleotides) due to the amount of about
0.006 pg of 4-ABP present in the blank.
Reproducibility was assessed by sampling
e performed to in triplicate for nine different samples, and
BP hydrolyzed the coefficient ofvariation was estimated to
kBP-adducted be 9.7%.
hydrolysis con- To validate this method for DNA with
kBP-modified unknown levels of the adduct, eight DNA
I]dG-C8-ABP samples, isolated from S. typhimurium
.ing a variety of strains TA1538 and TA98 incubated with
i nr11112- W-1r t r
drazine hydrate
N and incuba-
m temperature
at the optimal
iOH overnight
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Figure 2. Standard curve for alkaline hydrolysis and
GC-NICI-MS of 4-ABP adducts from in vitro
[3H]N-hydroxy-ABP-modified DNA. Each point repre-
sents mean value ± SE from three analyses in different
batches. In most cases errorbars are within the symbols.
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Figure 3. Correlation of 4-ABP-adduct analysis
obtained by either alkaline hydrolysis and
GC-NICI-MS or32P-postlabeling.
Figure 4. Autoradiograms of 4-ABP-DNA adducts analyzed by 32P-postlabeling. (A) [3H]N-hydroxy-ABP-modified
DNA standard and (B) DNA from S. typhimurim strains TA1538 and TA98 treated with 4-ABP ("Materials and
Methods"). The dG-C8-ABP spot is marked with arrow.
different concentrations of 4-ABP under
the conditions used for determination ofits
S9-mediated mutagenicity, were analyzed
by GC-NICI-MS and by the 32P-postla-
beling technique. There was complete
agreement between the two methods,
although the 32P-postlabeling method gave
slightly higher values, especially at high
adduct levels (Figure 3). The correlation
coefficient was 0.994 (p<0.001). These
results indicate that the alkaline hydrolysis
and GC-NICI-MS analysis method is reli-
able and it is comparable to 32P-postlabeling
technique for quantitation of dG-C8-ABP
at the adduct levels analyzed. Typical auto-
radiograms of 32P-postlabeled [3H]N-
hydroxy-ABP-modified DNA and DNA
isolated from S. typhimurium are shown in
Figure 4.
Application ofthe Method to Hwnan
Thsue DNA
Eleven human lung and eight human urinary
bladder mucosa DNA samples were ana-
lyzed for dG-C8-ABP adducts. The results,
summarized in Table 1 and Figure 5, indi-
cate that 10 of 11 lung DNA samples and
5 of 8 urinary bladder mucosa DNA sam-
ples were positive. The GC-NICI-MS
traces of one ofthese positive DNA samples
are shown in Figure 1B and 1 C, respec-
tively. The adduct levels in lung DNAvaried
among the individuals, ranging from <0.32
to 49.5 adducts in 108 nucleotides.
However, the adduct levels did not seem to
be directly related to the numbers of ciga-
rettes smoked per day or the duration of
smoking (Table 1). The adduct levels in
the eight urinary bladder mucosa DNA
ranged from <0.32 to 3.9 adducts in 108
nucleotides (Figure 5), indicating that the
adduct levels are comparable in both the
lungs and the urinary bladder.
Discussion
Based on the previous work on the hydrolysis
of carcinogenic arylamine-nucleoside
adducts (11,12), we have investigated the
alkaline hydrolysis of 4-ABP-modified
DNA. We found that 59% of 4-ABP
bound to DNA could be liberated by
hydrolysis with 0.05 N NaOH at 130°C
overnight. The efficiency of the hydrolysis
of the adducts and the minimal interfer-
ence in the samples, as seen in Figure 1, has
enabled application of the GC-NICI-MS
method to quantitate trace amounts of
4-ABP hydrolyzed by the procedure. With
[3H]N-hydroxy-ABP-modified DNA stan-
dards, the method is sensitive to levels as
low as 10 fmole 4-ABP per mg DNA (0.32
adduct/103 nucleotides using 100 j'g
DNA). The method has been used to
quantify adduct levels up to one adduct per
104 nucleotides, and the curve is linear in
this range (r = 0.999, Figure 2). These
results indicate that this method provides
both high selectivity and sensitivity
required for detection and quantification of
the adduct at levels found in human bio-
logical samples (10,18). We also compared
this GC-NICI-MS method to the most
widely used 32P-postlabeling technique in
analysis of dG-C8-ABP in the same DNA
samples. The results show that these two
methods are highly correlated, although the
32P-postlabeling method gave slightly
higher absolute values (Figure 3). This sug-
gests that the GC-NICI-MS method is
reliable and comparable to the 32P-postla-
beling method for the determination of
4-ABP-DNA adducts at the levels analyzed.
Tobacco smoking is implicated as an
etiologic factor in human lung and urinary
bladder cancers (19-22). 4-ABP, among
other aromatic carcinogens in tobacco
smoke, is likely to play a role in these dis-
4
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I:i
R< 0.321
1 2 3 4 5 6 7 8
Sample number
Figure 5. 4-ABP-DNA adducts in human urinary blad-
der mucosa.
eases because 4-ABP-DNA adducts were
detected in smokers' lungs and urinary
bladder (8-10). Using the GC-NICI-MS
method, we have confirmed these previous
findings. The adduct was found in almost
all lungs and five of eight of the urinary
bladders and the levels in both lungs and
urinary bladder were comparable. Lack of
correlation ofthe adduct levels in smokers'
lungs to the number of cigarettes smoked
may reflect limited sample size as well as
the differences in actual intake of 4-ABP,
which can be affected by smoking habits,
such as brand of cigarette used (1,23) and
the extent of smoke inhalation. Moreover,
the biologic uptake and distribution of the
carcinogens, metabolic phenotype, and
DNA repair mechanisms are well known to
vary greatly from individual to individual
(23,24), and these factors undoubtedly
contributed to the variations in the adduct
formation. The differences in the sampling
ofthe lung tissue also would result in varia-
tions of the DNA adduct levels because
biochemical processes ofthe adduct forma-
tion are dependent on cell type, the anatomic
location ofthe cells, and differentiated state
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of the cells (25,26). These lung tissue
specimens were not sampled from the same
anatomic location. Therefore, the result
does not necessarily mean that the adducts
are not relevant to cigarette smoke.
4-ABP-DNA adducts also can be quan-
titated by the 32P-postlabeling method and
immunochemical assays (9,10). While
immunochemical assays may provide sensi-
tivity required for human biomonitoring,
the accuracy ofthe method can be compro-
mised by cross-reactivity of the antibodies
with unknown contaminants. The
32P-postdabeling technique is a widely used
method and has been applied to analysis of
4-ABP-DNA adducts in human DNA in
several studies carried out in this laboratory
and others (10,18). This method is highly
sensitive and requires only low microgram
amounts of DNA for analysis. However,
the quantitation is compromised when the
authentic adduct is not available for use as
a chromatographic standard, and accurate
measurements are difficult when it is
applied to human tissue DNA, especially
smokers' lung DNA, because the 4-ABP-
adduct spots are usually located in the
diagonal zone of radioactivity. Attempts
were made in the current study to correlate
the 32P-postlabeling method to the
GC-NICI-MS method for quantitation of
4-ABP adducts in human urinary bladder
DNA, but it was not successful due to the
difficulty in precisely measuring 32P
radioactivity in half the cases in which the
adduct spots were located in the diagonal
zone (data not shown). Under our experi-
mental conditions, however, the
GC-NICI-MS method obviated this
problem for the adduct analysis and offered
not only relatively high selectivity and sen-
sitivity but also accuracy.
In conclusion, we have shown that
4-ABP-DNA adducts can be detected reli-
ably by alkaline hydrolysis and
GC-NICI-MS analysis. This method is
sensitive, structure-selective, and appears to
be useful for molecular dosimetry of
human exposure to the carcinogen 4-ABP.
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